NCT06495931View on ClinicalTrials.gov

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

HRS-1780 tablets

HRS-1780 tablets, three times

DRUG

HR20033 tablets

HR20033 tablets, nine times

DRUG

HRS-7535 tablets

HRS-7535 tablets ，three times or nine times

Trial Locations (1)

100032

Xuanwu Hospital ,Capital Medical University, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06495931 - Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human | Biotech Hunter | Biotech Hunter